chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Arm is just so itchy; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6208), via an unspecified route of administration in the arm left on 19Mar2021 at 16:00(at the age of 26-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, endometriosis, cystitis interstitial and immune thrombocytopenic purpura (ITP) from an unknown date. The patient was allergic to banana, pineapple, latex and prednisone. Concomitant medications included cetirizine hydrochloride (ZYRTEC), levonorgestrel (KYLEENA), AFFAIR and SINGULAR started on an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 19:00, the patient's arm was just so itchy, even 4-5 days later. There was no redness. It was not even warm. But the inside of patient arm itches so badly. The patient did not receive any treatment for the event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event arm just so itchy was resolving. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151), via an unspecified route of administration in the arm left on 02Apr2021, as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain
Clinical narrative: Shooting pain in legs; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021 at 09:00, the patient experienced shooting pain in legs and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events shooting pain in legs and weakness was not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment, Vitreous floaters
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 19Mar2021 at 12:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included arthritis in the right shoulder and seasonal and pet dander allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and fluticasone propionate (FLONASE) from unknown dates taken for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Mar2021 at 12:00, 2 days after the shot the patient came in from outside and her vision became dark, it had been sunny outside and this was not normal for the patient and few days after that the patient was in shower and vision was funny. On 05Apr2021, 17 days after the shot, the patient was looking at her phone screen in the evening and experienced weird splotches in vision. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events vision became dark, vision was funny and weird splotches in vision was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Vaccination site pain
Clinical narrative: Body ache; tiredness; chills; headache; pain at injection site; This is a spontaneous report from a contactable consumer. A 38-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 05Apr2021 at 17:00 (at the age of 38-year-old), as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021, the patient experienced body ache, tiredness, chills, headache and pain at injection site. The patient did not receive any treatment for the adverse events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event body ache, tiredness, chills, headache, pain at injection site was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Fatigue, Headache, Pain
Clinical narrative: Tired; Achy; Runny nose; Cough; 98.3 Fever; Headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the arm left on 31Mar2021 at 12:15 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, metabolic syndrome, hyperlipidaemia and coronary disease. Concomitant medications included acetylsalicylic acid (ASPIRIN), metoprolol succinate (METOPROLOL), losartan potassium (LOSARTAN), atorvastatin calcium (ATOR) and multi vitamin. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 22:00 the patient felt tired, achy, runny nose, cough, fever of 98.3, headache and sore arm. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tired, achy, runny nose, cough, fever of 98.3, headache and sore arm was recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: Tired; Achy; Runny nose; Cough; 98.3 Fever; Headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the arm left on 31Mar2021 at 12:15 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, metabolic syndrome, hyperlipidaemia and coronary disease. Concomitant medications included acetylsalicylic acid (ASPIRIN), metoprolol succinate (METOPROLOL), losartan potassium (LOSARTAN), atorvastatin calcium (ATOR) and multi vitamin. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 22:00 the patient felt tired, achy, runny nose, cough, fever of 98.3, headache and sore arm. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tired, achy, runny nose, cough, fever of 98.3, headache and sore arm was recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Nodule, Paraesthesia
Clinical narrative: Both legs started to burn; Both legs started to burn then tingle; A nickle sizelump appeared on my calf and isextremely painful to the tough. It isvery hard all around the lump andfeels like a coin under the skin.; A nickle sizelump appeared on my calf and isextremely painful to the tough. It isvery hard all around the lump andfeels like a coin under the skin.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 31Mar2021 at 15:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included pseudoephedrine sulfate, loratadine (CLARITIN D 12 HOUR) for unknown indication from an unknown date. The patient had no known allergies to medications, food, or other products. The patient previously, received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration on 11Mar2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 21:00, 6 hours after injection the patient experienced burning sensation in both legs then tingle, immediately after that, a nickle size lump appeared on the calf. The lump was extremely painful to the touch, that was very hard all around the lump and felt like a coin under the skin. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events burning leg, tingling, nodule and painful nodule were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea, Pain, Pyrexia
Clinical narrative: diarrhea; chills; aches; low grade fever; nausea; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6200) via an unspecified route of administration in the left arm on 23Feb2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had reported no known allergies. Concomitant medications included rosuvastatin ((MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) from unknown date for unspecified indication.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01Mar2021, the patient experienced diarrhoea for 3 days, chills, aches, low grade fever and nausea. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit. No therapeutic measures were taken as the result of adverse events. The clinical outcome of the events diarrhoea was recovered on 03Mar2021, and the events chills, aches, low grade fever and nausea were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Developing rashes. Rashes are small, red, and clustered. Non itchy and non painful; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 31Mar2021 at 18:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease(Ckd) and systemic lupus erythematosus (lupus). Concomitant medications were not reported. The patient had no f known allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 00:00, the patient experienced rashes and rashes were small, red, and clustered. Non itchy and non-painful. The event resulted in emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event red rash was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metal taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 06Apr2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto thyroiditis. The patient had history of known allergies to morphine (MANUFACTURER UNKNOWN). Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), tamsulosin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and amlodipine (AMLODIPIN); all from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 13:00, the patient experienced metal taste in mouth. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The outcome of metal taste in mouth was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 13:00 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced severe headache. The event did not result in doctor or other healthcare professional office/clinic visit or emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event severe headache was resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal stiffness, Neck pain, Vaccination site pain
Clinical narrative: Arm sore at the vaccination site; Intense soreness and stiffness around neck/ shoulder blade; Intense soreness and stiffness around neck/ shoulder blade; Intense soreness and stiffness around neck/ shoulder blade; neck stiffness / intense soreness and stiffness around neck/shoulder blade; This is a spontaneous report received from a contactable consumer (patient). A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 11:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included Sulfa allergy from an unknown date. Concomitant medications included ethinylestradiol, levonorgestrel (LEVORA) taken for an unspecified indication, start and stop date were not reported.  The patient experienced neck stiffness / intense soreness and stiffness around neck/shoulder blade on 23Mar2021, at 11:45 with outcome of not recovered, arm sore at the vaccination site  on 02Apr2021, at 07:00 with outcome of not recovered. Details were as follows: On 23Mar2021, when receiving the vaccine, the patient experienced neck stiffness. The day after the vaccine, the patient no longer had any arm soreness or neck stiffness. On 02Apr2021 at 07:00, 9 days after the vaccination, the patient experienced arm sore at the vaccination site, intense soreness and stiffness around neck/ shoulder blade. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of neck stiffness / intense soreness and stiffness around neck/shoulder blade and arm sore at the vaccination site was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Nausea
Clinical narrative: Fever; Chills; Fatigue; Body aches; Nausea / Vomiting; Nausea / Vomiting; Head ache; This is a spontaneous report received from a contactable consumer (patient) via a regulatory authority. An 18-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot Number: ER8733) via an unspecified route of administration in the right arm on 30Mar2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient medical history was not reported. There were no concomitant medications.  The patient experienced head ache on 31Mar2021 with outcome of recovered in Apr2021.  On 01Apr2021,at 23:00 the patient also experienced fever, chills, fatigue, body aches, nausea / vomiting. The patient underwent lab tests and procedures which included body temperature: from 101 to 102.3  on 01Apr2021.  Details were as follows: On 31Mar2021, the patient experienced headache for 24 hours,  On 01Apr2021 at 23:00, noted fever (ranging from 101 to highest 102.3), chills, fatigue, body aches and nausea/vomiting. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache was recovered on 01Apr2021 (for a duration of 24 hours), The clinical outcome of fever, chills, fatigue, body aches and nausea/vomiting was recovered in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vomiting
Clinical narrative: Fever; Chills; Fatigue; Body aches; Nausea / Vomiting; Nausea / Vomiting; Head ache; This is a spontaneous report received from a contactable consumer (patient) via a regulatory authority. An 18-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot Number: ER8733) via an unspecified route of administration in the right arm on 30Mar2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient medical history was not reported. There were no concomitant medications.  The patient experienced head ache on 31Mar2021 with outcome of recovered in Apr2021.  On 01Apr2021,at 23:00 the patient also experienced fever, chills, fatigue, body aches, nausea / vomiting. The patient underwent lab tests and procedures which included body temperature: from 101 to 102.3  on 01Apr2021.  Details were as follows: On 31Mar2021, the patient experienced headache for 24 hours,  On 01Apr2021 at 23:00, noted fever (ranging from 101 to highest 102.3), chills, fatigue, body aches and nausea/vomiting. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache was recovered on 01Apr2021 (for a duration of 24 hours), The clinical outcome of fever, chills, fatigue, body aches and nausea/vomiting was recovered in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Paraesthesia, Taste disorder
Clinical narrative: strange sensation in the front of head; weird taste in mouth; right above eyes where it felt like something was tingling/ coarsing through a vein; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm right on 27Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, visual impairment and also reported to have a very bad eyesight in left eye and had a posterior vitreous detachment back in 2015. The patient did not report any allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) 25mg from unknown date; for unknown indication and famotidine (MANUFACTURER UNKNOWN) 5mg from unknown date; for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 at 16:00 the patient experienced strange sensation in the front of head, and around the forehead right above eyes where it felt like something was tingling/ coarsing through a vein (localized tingling). Patient had a very bad eyesight in left eye and had a posterior vitreous detachment back in 2015. It felt like something was happening like that when floaters started occurring in eye. Patient also felt a weird taste in mouth like when something drips down the back of your throat. This occurred a second or two after the forehead feeling and felt like if you snort something and you could taste it in your mouth slightly. Patient further stated that both of these things lasted less than a minute, possibly only like maybe up to 40 seconds. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. Patient did not receive any treatment for the events. The clinical outcome of the event strange sensation in front of head, right above eyes where it felt like something was tingling/ coarsing through a vein (localized tingling) and weird taste in mouth were recovered on 27Mar2021 at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Axillary pain, Ear pain, Facial pain, Nausea
Clinical narrative: pain on my arm; nausea; shaking, tremors; low grade fever; stomach upset; mild sore throat; moderate body aches; high intensity pain on the right neck (sameside as vaccine), very difficult to turn head side by side because of pain on neck; intense pain on armpit; pain on half of the face (opposite side of vaccine); pain on half of the face (opposite side of vaccine) and left ear; This is a spontaneous report from a non-contactable other healthcare professional. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm right on 29Mar2021 at 08:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 22:00, after the second dose, the patient experienced pain on the arm, nausea, shaking, tremors, low grade fever, stomach upset, mild sore throat, moderate body aches, high intensity pain on right neck (same side as vaccine), very difficult to turn head side by side because of pain on the neck, intense pain on armpit that lasted a full week from monday to sunday. The patient also had pain on half of the face (opposite side of vaccine) and the left ear only during the first night after vaccine. The patient did not receive any treatment for the events. The clinical outcome of the events pain on the arm, nausea, shaking, tremors, low grade fever, stomach upset, mild sore throat, moderate body aches, high intensity pain on right neck (same side as vaccine), pain on half of the face (opposite side of vaccine) was resolved on an unknown date in 2021 and that of intense pain on armpit was resolved on 04Apr2021 and the clinical outcome of left ear pain was resolved on 30Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Oropharyngeal pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: pain on my arm; nausea; shaking, tremors; low grade fever; stomach upset; mild sore throat; moderate body aches; high intensity pain on the right neck (sameside as vaccine), very difficult to turn head side by side because of pain on neck; intense pain on armpit; pain on half of the face (opposite side of vaccine); pain on half of the face (opposite side of vaccine) and left ear; This is a spontaneous report from a non-contactable other healthcare professional. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm right on 29Mar2021 at 08:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 22:00, after the second dose, the patient experienced pain on the arm, nausea, shaking, tremors, low grade fever, stomach upset, mild sore throat, moderate body aches, high intensity pain on right neck (same side as vaccine), very difficult to turn head side by side because of pain on the neck, intense pain on armpit that lasted a full week from monday to sunday. The patient also had pain on half of the face (opposite side of vaccine) and the left ear only during the first night after vaccine. The patient did not receive any treatment for the events. The clinical outcome of the events pain on the arm, nausea, shaking, tremors, low grade fever, stomach upset, mild sore throat, moderate body aches, high intensity pain on right neck (same side as vaccine), pain on half of the face (opposite side of vaccine) was resolved on an unknown date in 2021 and that of intense pain on armpit was resolved on 04Apr2021 and the clinical outcome of left ear pain was resolved on 30Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: pain on my arm; nausea; shaking, tremors; low grade fever; stomach upset; mild sore throat; moderate body aches; high intensity pain on the right neck (sameside as vaccine), very difficult to turn head side by side because of pain on neck; intense pain on armpit; pain on half of the face (opposite side of vaccine); pain on half of the face (opposite side of vaccine) and left ear; This is a spontaneous report from a non-contactable other healthcare professional. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm right on 29Mar2021 at 08:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 22:00, after the second dose, the patient experienced pain on the arm, nausea, shaking, tremors, low grade fever, stomach upset, mild sore throat, moderate body aches, high intensity pain on right neck (same side as vaccine), very difficult to turn head side by side because of pain on the neck, intense pain on armpit that lasted a full week from monday to sunday. The patient also had pain on half of the face (opposite side of vaccine) and the left ear only during the first night after vaccine. The patient did not receive any treatment for the events. The clinical outcome of the events pain on the arm, nausea, shaking, tremors, low grade fever, stomach upset, mild sore throat, moderate body aches, high intensity pain on right neck (same side as vaccine), pain on half of the face (opposite side of vaccine) was resolved on an unknown date in 2021 and that of intense pain on armpit was resolved on 04Apr2021 and the clinical outcome of left ear pain was resolved on 30Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Vomiting
Clinical narrative: Dizziness; vomitting; Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN8734) via an unspecified route of administration in the left arm on 05Apr2021 at 13:45 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other medications within two weeks of vaccination. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 14Mar2021 at 16:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021, the patient experienced dizziness, vomiting, headache and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The clinical outcome of the events dizziness, vomiting, headache and chills was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy
Clinical narrative: Swollen lymph nodes on left collarbone; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included no serious illness and had full left hip replacement. The patient had no known allergies The concomitant medication was taken by the patient (unspecified) within two weeks prior to COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En6205) via an unspecified route of administration in the left arm on 05Mar2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 08:00, eight days after vaccine, the patient experienced swollen lymph nodes on left collarbone and fatigue day three through eleven. The events resulted in doctor or other healthcare professional office or clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the events swollen lymph nodes and fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, SARS-CoV-2 test
Clinical narrative: severe rash all over upper chest, breasts, upper shoulders red, pimply with whiteheads; severe rash all over upper chest, breasts, upper shoulders red, pimply with whiteheads; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 14:00 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date prior to the vaccination and known allergy to penicillin. Concomitant medications included norethisterone acetate, ethinylestradiol, ferrous fumarate (CHARLOTTE 24 FE) 1 daily for birth control from unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced severe rash all over upper chest, breasts, upper shoulders. The rash was not itchy and did not hurt or burn, just red and pimply with whiteheads. The patient underwent lab tests and procedures which included nasal swab for COVID-19 virus test on 06Apr2021 and the results were pending. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event rash and red rash was recovered on an unknown date 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pyrexia
Clinical narrative: temperature; fatigue; overall malaise; This is a spontaneous report from a contactable consumer. A female patient of an unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown if the patient received other medications in two weeks. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, it was unknown, if the patient was diagnosed with COVID-19. It was unknown if the patient had tested for COVID-19 since having the vaccine. On 04Apr2021, the patient experienced temperature, fatigue and overall malaise. It was unknown if the patient received treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events temperature, fatigue, and malaise was recovered on an unspecified date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Odynophagia
Clinical narrative: Upper chest pain; coughing; hurt swallowing food; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 17:45 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, anxiety and known allergy to sulfa drugs. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and naproxen (MANUFACTURER UNKNOWN); both for unspecified indications from unknown start dates. The patient previously took trimethobenzamide hydrochloride (TIGAN) for unspecified indication from unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 12:00, the patient experienced upper chest pain that went to back, both sides and hurt with movement, coughing and swallowing food. The adverse events resulted in emergency room or department visit or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events chest pain, coughing and swallowing painful was recovering at the time of reporting.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Swelling, Tenderness
Clinical narrative: The next day swelling is still there, along with redness; The next day swelling is still there, along with redness, warmness to touch; itchiness; First day was swelling/ palm is swollen; tenderness/Whole left arm feels tender, and palm is swollen and tender.; This is a spontaneous report from a non-contactable consumer, the patient,  via COVID-19 Adverse Event Self-Reporting Solution (COVAES).   A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 7533), via an unspecified route of administration, in the left arm on 01Apr2021 at 09:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation.  Medical history included COVID-19 prior to vaccination from an unknown date to an unknown date. The patient had no allergies to food, medication or other products. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medications within two weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior of the vaccination. On 02Apr2021, the patient experienced swelling and tenderness. On 03Apr2021,the next day swelling was still there, along with redness, warmness to the touch, and itchiness. The whole left arm felt tender, and palm was swollen and tender. The patient did not receive any treatment for the events. The clinical outcomes of swelling, tenderness, warmth, redness and itchiness was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Paraesthesia
Clinical narrative: As soon as the shot was administered I began to feel lightheaded. I felt a tingling sensation spread across my face and upper body and it took a lot of willpower to focus. This effect lasted strongly; I felt a tingling sensation spread across my face and upper body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Patient was allergic to food dyes and additives when younger. Concomitant medications included ethinlyestradiol; etonogestrel (NUVARING), vitamin d (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC) from unknown date and unspecified indication. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:00, as soon as the shot was administered patient began to feel lightheaded and she felt a tingling sensation spread across her face and upper body and it took a lot of willpower to focus. This effect lasted strongly for 2 hours, and even by the end of the day she could feel residual effects. It was very similar to patient experienced donating platelets and her body response to the citrate. A physician friend thought it may be an anxiety response to needles, but patient stated that she had absolutely no fear of needles and had given blood many times without this effect. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheaded and tingling were recovered on 02Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Lymphadenopathy
Clinical narrative: Lymph node is swollen and uncomfortable under left arm pit.; Uncomfortable under left arm pit.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 05Apr2021 at 10:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraines, seasonal allergy and allergy to NSAIDS. Concomitant medications included tizanidine (MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN), sumatriptan (IMITREX), paracetamol (TYLENOL) and multi v (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 15Mar2021 at 10:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation and took aspirin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 06:30, the patient experienced lymph node was swollen and uncomfortable under left arm pit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lymph node was swollen and uncomfortable under left arm pit was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Swelling face
Clinical narrative: Face became immediately hot; face became red; face became swollen; This is a spontaneous report from a contactable consumer, the patient, via COVID-19 Adverse Event Self-Reporting Solution.   A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6201), via an unspecified route of administration  in the left arm on 19Mar2021  at 10:00 (at the age of 66-years-old) as as single dose for COVID-19 immunisation.  Medical history included hypertension and chronic Lyme disease; both from unknown dates and unknown if ongoing.  The patient's concomitant medications were not reported.  On 19Mar2021 at 10:00, the patient's face became immediately hot, red and swollen.  Therapeutic measures were taken as a result of face became hot, red and swollen and included treatment with ice packs, diphenhydramine (BENADRYL) and unspecified steroids. The clinical outcome of the patient's face became immediately hot, red and swollen was not recovered.   No follow-up attempts are required. No further information is expected.